With new approvals for cardiovascular risk reduction and OSA, GLP1s are reshaping treatment paradigms across comorbid conditions and gaining traction with a broader set of providers
B12 is water-soluble, meaning your body uses what it needs and safely eliminates the rest making it a low-risk, high-reward treatment for most people
It also means reaching clinically meaningful thresholds, like a 10% or 20% reduction, sooner, which translates to earlier improvements in comorbidities like type 2 diabetes, hypertension, and sleep apnea
In 2023, semaglutide was the best-selling drug in the United States with nearly $14 billion in sales.1 There are an estimated 100 million obese adults in America, and an additional 37 million who may also be eligible to use medications like GLP-1s to manage chronic conditions
You can find supplements with these ingredients in pill form, but injections are usually much more effective